Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

NCT00500331 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: GSK189075
DRUG: pioglitazone
OTHER: Placebo

Sponsor

GlaxoSmithKline